Spots Global Cancer Trial Database for eloxatin
Every month we try and update this database with for eloxatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma | NCT00861783 | Hepatoma Advanced Solid ... | irinotecan and ... oxaliplatin and... | 18 Years - | Traws Pharma, Inc. | |
| Gemox as First and Second Line Therapy in Unknown Primary Cancer | NCT00353145 | Unknown Primary... | Gemcitabine (Ge... Oxaliplatin Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma | NCT00861783 | Hepatoma Advanced Solid ... | irinotecan and ... oxaliplatin and... | 18 Years - | Traws Pharma, Inc. | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma | NCT02062749 | Colorectal Canc... | Oxaliplatin | 9 Years - 21 Years | M.D. Anderson Cancer Center | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater | NCT01202409 | Gastrointestina... | Panitumumab | 18 Years - | M.D. Anderson Cancer Center | |
| Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma | NCT02062749 | Colorectal Canc... | Oxaliplatin | 9 Years - 21 Years | M.D. Anderson Cancer Center | |
| XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib | NCT00920868 | Solid Tumor Metastatic Colo... | dasatinib bevacizumab Oxaliplatin Capecitabine | 18 Years - | Duke University | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center | |
| XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib | NCT00920868 | Solid Tumor Metastatic Colo... | dasatinib bevacizumab Oxaliplatin Capecitabine | 18 Years - | Duke University | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Folfox-B Study for Patients With Colorectal Liver Metastases | NCT00508872 | Colorectal Live... | 5-Fluorouracil Bevacizumab Leucovorin Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | NCT00501410 | Colorectal Canc... | 5-FU Cetuximab Dasatinib Leucovorin Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab | NCT01213238 | Advanced Cancer... | Oxaliplatin Capecitabine Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab | NCT01213238 | Advanced Cancer... | Oxaliplatin Capecitabine Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center | |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | NCT00526110 | Gastrointestina... | 5-Fluorouracil Docetaxel Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Azacitidine and CAPOX in Metastatic Colorectal Cancer | NCT01193517 | Colorectal Canc... | Azacitidine Capecitabine Oxaliplatin Azacitidine MTD | 18 Years - | M.D. Anderson Cancer Center | |
| Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL | NCT00452374 | Leukemia | Cytarabine Fludarabine Oxaliplatin Rituximab | 18 Years - | M.D. Anderson Cancer Center | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00093379 | Anal Cancer | Capecitabine Oxaliplatin Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | NCT00338039 | Pancreatic Canc... | Cetuximab Gemcitabine Oxaliplatin Capecitabine Radiotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | NCT00338039 | Pancreatic Canc... | Cetuximab Gemcitabine Oxaliplatin Capecitabine Radiotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | NCT00690300 | Pancreas Neopla... | Docetaxel Oxaliplatin | 18 Years - | University of Ulm | |
| Folfox-B Study for Patients With Colorectal Liver Metastases | NCT00508872 | Colorectal Live... | 5-Fluorouracil Bevacizumab Leucovorin Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | NCT00941499 | Advanced Cancer... | HAI Oxaliplatin 5-FU Bevacizumab Cetuximab Leucovorin 5-FU Bevacizumab | - | M.D. Anderson Cancer Center | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma | NCT00338988 | Cancer of the G... Cancer of the B... | Capecitabine Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver | NCT00803647 | Metastatic Colo... | cetuximab 5-FU oxaliplatin leucovorin | 18 Years - | NSABP Foundation Inc | |
| Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater | NCT00354887 | Gastrointestina... | Capecitabine Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Folfox-B Study for Patients With Colorectal Liver Metastases | NCT00508872 | Colorectal Live... | 5-Fluorouracil Bevacizumab Leucovorin Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | NCT00338039 | Pancreatic Canc... | Cetuximab Gemcitabine Oxaliplatin Capecitabine Radiotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | NCT00941499 | Advanced Cancer... | HAI Oxaliplatin 5-FU Bevacizumab Cetuximab Leucovorin 5-FU Bevacizumab | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
